As a… ahem… “seasoned” pharmacist and consultant I’ve seen a lot in my time. Historically plan sponsors have had to be highly vigilant with managing their pharmacy benefit programs. In my role of supporting these plan sponsors with clinical and vendor management expertise it can feel like a game of whack a mole – the moment you identify and correct an issue the next one has popped up.
The following list captures my current top three moles, if you will, where plan sponsors are spending more than needed compared to the clinical value their members are receiving.
Rising drug costs have placed tremendous pressure on plan sponsors – forcing them to serve as detectives trying to uncover waste and unnecessary utilization within their pharmacy benefit program. The good news is that you don’t have to do it alone. PSG’s team of clinical and data experts empower benefit leaders with the insights and analytics to make the right decisions for your members.
Download PSG’s overview to learn how we can be your advocate for a clinically and financially optimal pharmacy benefit.